Athersys Inc., of Cleveland, and Cell Therapy Catapult in London said Athersys affiliate Athersys Ltd. was awarded a grant from Innovate UK to support a phase IIa study evaluating the administration of Multistem cell therapy to acute respiratory distress syndrome patients.